138 related articles for article (PubMed ID: 15598581)
1. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
[TBL] [Abstract][Full Text] [Related]
2. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
Pietra G; Mortarini R; Parmiani G; Anichini A
Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dendritic cell interleukin-12 secretion by tumour cell necrosis.
Kandil H; Bachy V; Williams DJ; Helmi R; Gotch FM; Ibrahim MA
Clin Exp Immunol; 2005 Apr; 140(1):54-64. PubMed ID: 15762875
[TBL] [Abstract][Full Text] [Related]
4. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
[TBL] [Abstract][Full Text] [Related]
5. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.
Di Nicola M; Napoli S; Anichini A; Mortarini R; Romagnoli L; Magni M; Matteucci P; Baldassarri P; Bersani I; Carlo-Stella C; Gianni AM
Haematologica; 2003 Dec; 88(12):1396-404. PubMed ID: 14687994
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.
Salio M; Cerundolo V; Lanzavecchia A
Eur J Immunol; 2000 Feb; 30(2):705-8. PubMed ID: 10671230
[TBL] [Abstract][Full Text] [Related]
8. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets.
Dalgaard J; Beckstrøm KJ; Jahnsen FL; Brinchmann JE
J Leukoc Biol; 2005 May; 77(5):689-98. PubMed ID: 15728242
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer.
Weise JB; Csiszar K; Gottschlich S; Hoffmann M; Schmidt A; Weingartz U; Adamzik I; Heiser A; Kabelitz D; Ambrosch P; Görögh T
Int J Oncol; 2008 Feb; 32(2):317-22. PubMed ID: 18202753
[TBL] [Abstract][Full Text] [Related]
12. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ
Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
14. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
[TBL] [Abstract][Full Text] [Related]
16. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
[TBL] [Abstract][Full Text] [Related]
17. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
18. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
Strauss L; Volland D; Kunkel M; Reichert TE
Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
[TBL] [Abstract][Full Text] [Related]
19. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
